## Skeptic's Critique: Oxidative Stress Upstream of TDP-43
### Weakest Assumptions
**1. Unidirectional causality assumption.** The framework positions oxidative stress as the initiating event driving TDP-43 mislocalization. However, this ignores substantial evidence that TDP-43 pathology itself can *cause* oxidative stress. TDP-43 normally regulates nuclear-encoded mitochondrial genes; its cytoplasmic aggregation creates loss-of-function that directly impairs oxidative phosphorylation (Chung et al., 2020; PMID: 32176620). This creates a confound: observed mitochondrial ROS in ALS could be downstream of TDP-43 dysfunction, not upstream.
**2. NRF2 activation ≠ neuroprotection in humans.** While NRF2 activators show efficacy in SOD1 mouse models, the clinical translation has been disappointing. Edaravone (an ROS scavenger) provides only modest benefit (PMCID: PMC6419469), and broad NRF2 activators have not succeeded in ALS trials. This suggests the rodent model may overestimate upstream oxidative stress pathogenicity.
**3. Antioxidant interventions fail in sporadic ALS.** Multiple large trials (selegiline, vitamin E, coenzyme Q10) targeting oxidative stress have failed (Cudkowicz et al., 2008; PMID: 18704095). If oxidative stress were the primary upstream trigger, these interventions should show greater efficacy.
### Alternative Explanations
**1. TDP-43 aggregation drives oxidative stress independently.** Nuclear TDP-43 loss-of-function disrupts chaperone and mitochondrial gene expression, creating a feedforward loop where proteostasis failure leads to mitochondrial dysfunction. Oxidative modifications to TDP-43 may be epiphenomena rather than drivers.
**2. Primary proteostasis collapse upstream of both.** ER stress, proteasome impairment, and stress granule dysregulation may be the initiating insult, with both TDP-43 mislocalization and oxidative stress emerging as secondary consequences of upstream protein homeostasis failure.
### Falsification Experiments
1. **Genetically separate oxidative stress from TDP-43 pathology:** Cross SOD1^G93A^ mice with TDP-43 knockdown or mutation models. If oxidative stress is truly upstream, disease should still progress despite attenuated TDP-43 pathology.
2. **Test if NRF2 activation prevents TDP-43 mislocalization in TDP-43 mutation models (non-SOD1):** iPSC-derived motor neurons from TDP-43 A315T or M337V carriers treated with CDDO-Me. If NRF2 activation doesn't prevent TDP-43 mislocalization, the upstream hypothesis fails.
### Revised Confidence Score: **0.35**
The bidirectional causality problem and clinical trial failures substantially weaken this framework. While oxidative stress contributes to ALS pathogenesis, positioning it as the primary upstream driver is likely an oversimplification.